Safety evaluation of the food enzyme glutaminase from the genetically modified Bacillus subtilis strain Glu3‐3 Authors: EFSA Panel on Food Enzymes (FEZ), Holger Zorn, José Manuel Barat Baviera, Claudia Bolognesi, Francesco Catania, Gabriele Gadermaier, Ralf Greiner, Baltasar Mayo, Alicja Mortensen, Yrjö Henrik Roos, Marize L M Solano, Henk Van Loveren, Laurence Vernis, Jaime Aguilera, Magdalena Andryszkiewicz, Daniele Cavanna, Yi Liu Published: 2026 ABSTRACT AbstractThe food enzyme glutaminase (l‐glutamine amidohydrolase; EC 3.5.1.2) is produced with the genetically modified Bacillus subtilis strain Glu3‐3 by Angel Yeast Co., Ltd. The production strain of the food enzyme contains multiple copies of acquired antimicrobial resistance genes. The food enzyme was considered free of viable cells of the production strain, but the absence of DNA was not demonstrated. As no other concerns arising from the microbial source or from the manufacturing process have been identified, the Panel considered that toxicological tests are not needed for the assessment of this food enzyme. The food enzyme is intended to be used in seven food manufacturing processes. Dietary exposure was estimated to be up to 29.311 mg total organic solids/kg body weight per day in European populations. A search for the homology of the amino acid sequence of the glutaminase to known allergens was made and no match was found. The Panel considered that a risk of allergic reactions upon dietary exposure cannot be excluded, but that the likelihood is low. Because the absence of DNA from the production organism in the food enzyme was not demonstrated, the Panel could not conclude on the safety of the food enzyme.Keywords: Bacillus subtilis, EC 3.5.1.2, EFSA‐Q‐2025‐00232, food enzyme, genetically modified microorganism, l‐glutaminase, l‐glutamine amidohydrolase INTRODUCTION Article 3 of the Regulation (EC) No 1332/2008 1 provides definition for ‘food enzyme’ and ‘food enzyme preparation’. ‘Food enzyme’ means a product obtained from plants, animals or microorganisms or products thereof including a product obtained by a fermentation process using microorganisms: (i) containing one or more enzymes capable of catalysing a specific biochemical reaction; and (ii) added to food for a technological purpose at any stage of the manufacturing, processing, preparation, treatment, packaging, transport or storage of foods. ‘Food enzyme preparation’ means a formulation consisting of one or more food enzymes in which substances such as food additives and/or other food ingredients are incorporated to facilitate their storage, sale, standardisation, dilution or dissolution. Before January 2009, food enzymes other than those used as food additives were not regulated or were regulated as processing aids under the legislation of the Member States. On 20 January 2009, Regulation (EC) No 1332/2008 on food enzymes came into force. This Regulation applies to enzymes that are added to food to perform a technological function in the manufacture, processing, preparation, treatment, packaging, transport or storage of such food, including enzymes used as processing aids. Regulation (EC) No 1331/2008 2 established the European Union (EU) procedures for the safety assessment and the authorisation procedure of food additives, food enzymes and food flavourings. The use of a food enzyme shall be authorised only if it is demonstrated that: it does not pose a safety concern to the health of the consumer at the level of use proposed; it does not pose a safety concern to the health of the consumer at the level of use proposed; there is a reasonable technological need; there is a reasonable technological need; its use does not mislead the consumer. its use does not mislead the consumer. All food enzymes currently on the EU market and intended to remain on that market, as well as all new food enzymes, shall be subjected to a safety evaluation by the European Food Safety Authority (EFSA) and approval via an EU Community list. Background and Terms of Reference as provided by the requestor Background as provided by the European Commission Only food enzymes included in the Union list may be placed on the market as such and used in foods, in accordance with the specifications and conditions of use provided for in Article 7(2) of Regulation (EC) No 1332/2008 on food enzymes. On 29 November 2024, a new application was submitted by “Angel Yeast Co., Ltd.” seeking authorisation for the food enzyme Glutaminase from genetically modified Bacillus subtilis (strain Glu3‐3). Terms of Reference The European Commission requests the European Food Safety Authority to carry out the safety assessment and the assessment of possible confidentiality requests of the following food enzyme: Glutaminase from genetically modified Bacillus subtilis (strain Glu3‐3) in accordance with Regulation (EC) No 1331/2008 establishing a common authorisation procedure for food additives, food enzymes and food flavourings.2 DATA AND METHODOLOGIES Data The applicant has submitted a dossier in support of the application for authorisation of the food enzyme glutaminase from B. subtilis Glu3‐3. Additional information were requested during the risk assessment phase. See. https://open.efsa.europa.eu/questions/EFSA‐Q‐2025‐00232. Methodologies The assessment was conducted in line with the principles described in the EFSA ‘Guidance on transparency in the scientific aspects of risk assessment’ (EFSA, 2009) and following the relevant guidance documents of the EFSA Scientific Committee. The ‘Scientific Guidance for the submission of dossiers on food enzymes’ (EFSA CEP Panel, 2021) and the ‘Food manufacturing processes and technical data used in the exposure assessment of food enzymes’ (EFSA CEP Panel, 2023) have been followed for the evaluation. Public consultation According to Article 32c(2) of Regulation (EC) No 178/2002 3 and to the Decision of EFSA's Executive Director laying down the practical arrangements on pre‐submission phase and public consultations, EFSA carried out a public consultation on the non‐confidential version of the technical dossier from 23 March to 13 April 2026. 4 No comments were received. ASSESSMENT IUBMB nomenclatureGlutaminaseSystematic name l‐glutamine amidohydrolaseSynonyms l‐glutaminase; glutamine aminohydrolaseIUBMB NoEC 3.5.1.2CAS No9001‐47‐2EINECS No618332‐5 Glutaminases catalyse the hydrolysis of the amide bond of L‐glutamine, releasing L‐glutamic acid and ammonia. The food enzyme under assessment is intended to be used in seven food manufacturing processes as defined in the EFSA guidance (EFSA CEP Panel, 2023): (1) processing of dairy products for the production of flavouring preparations from dairy products; (2) processing of egg and egg products; (3) processing of meat and fish products for the production of protein hydrolysates from meat and fish proteins; processing of cereals and other grains for the production of (4) baked products and (5) cereal‐based products other than baked; (6) processing of plant‐ and fungal‐derived products for the production of protein hydrolysates from plants and fungi; (7) processing of yeast and yeast products. Source of the food enzyme The glutaminase is produced with the genetically modified bacterium B. subtilis strain Glu3‐3, which is deposited ■■■■■ with the deposition number ■■■■■. 5 The production strain was identified as B. subtilis by whole genome sequence (WGS) analysis, showing average nucleotide identity and digital DNA–DNA hybridisation values of ■■■■■ in both cases to the reference genome of ■■■■■. 6 The species B. subtilis is included in the list of organisms for which the qualified presumption of safety (QPS) may be applied, provided that the absence of acquired antimicrobial resistance (AMR) genes and toxigenic activity are verified for the specific strain used (EFSA, 2007; EFSA BIOHAZ Panel, 2022). 7 In addition, the genetic modifications should not give rise to safety concerns. The strain was shown to be not cytotoxic ■■■■■. 8 However, the production strain carries genes conferring resistance to ampicillin, chloramphenicol and kanamycin resulting from the genetic modification (see Section 3.1.4). Therefore, the production strain cannot be considered to qualify for the QPS status. Characteristics of the parental and recipient microorganisms The recipient strain is ■■■■■ ■■■■■ ■■■■■. Characteristics of introduced sequences 10 The sequence encoding the glutaminase ■■■■■. ■■■■■. Description of the genetic modification The purpose of the genetic modification was to enable the production strain to synthesise glutaminase ■■■■■. The presence of the ■■■■■ in the production strain was confirmed ■■■■■. 11 Safety aspects of the genetic modification The technical dossier contains all necessary information on the recipient microorganism, the donor organism and the genetic modification process. The production strain B. subtilis Glu3‐3 differs from the recipient strain in its ability to produce glutaminase ■■■■■. The production strain ■■■■■, carrying resistance genes to ampicillin, chloramphenicol and kanamycin. The presence of these genes is considered a hazard, which is further discussed in this opinion. Production of the food enzyme The food enzyme is manufactured according to the Food Hygiene Regulation (EC) No 852/2004, 12 with food safety procedures based on Hazard Analysis and Critical Control Points, and in accordance with Good Manufacturing Practice. 13 The production strain is grown as a pure culture using a typical industrial medium in a submerged, fed‐batch system with conventional process controls in place. After completion of the fermentation, the solid biomass is removed from the fermentation broth by filtration. The filtrate containing the enzyme is then further purified and concentrated, including an ultrafiltration step in which the enzyme protein is retained, while most of the low molecular mass material passes the membrane and is discarded. Finally, the food enzyme is freeze‐dried in the presence of a stabiliser prior to analysis. 14 The applicant provided information on the identity of the substances used to control the fermentation and in the subsequent downstream processing of the food enzyme. 15 The Panel considered that sufficient information has been provided on the manufacturing process and the quality assurance system implemented by the applicant to exclude issues of concern. Characteristics of the food enzyme Properties of the food enzyme The glutaminase is composed of ■■■■■ amino acids and the molecular mass of the mature protein, calculated from the amino acid sequence, is ■■■■■ kDa. 16 The food enzyme was analysed by sodium dodecyl sulfate–polyacrylamide gel electrophoresis. 17 A consistent protein pattern was observed across all batches. No other enzyme activities were reported. The determination of glutaminase activity is based on the hydrolysis of L‐glutamine (reaction conditions: ■■■■■). The release of glutamic acid is quantified ■■■■■. The enzyme activity is expressed in Units (U)/g. One U is defined as the amount of enzyme that produces 1 μmol of glutamic acid per min under the assay conditions. 18 The food enzyme has a temperature optimum around ■■■■■ and a pH optimum around ■■■■■. Thermostability was tested by pre‐incubation of the food enzyme for 60 min at different temperatures ■■■■■. The enzyme activity decreased above 40°C showing no residual activity at 70°C. 19 Chemical parameters Data were provided for three batches of the food enzyme preparation intended for commercialisation (Table 1). 20 The mean total organic solids (TOS) was 39.9% and the mean enzyme activity/TOS ratio was 1.01 U/mg TOS. TABLE 1Composition of the food enzyme preparation.ParametersUnitBatches123 Glutaminase activity U/g a 401403401 Protein %10.413.810.6 Ash %4.84.94.9 Water %5.25.45.2■■■■■ (excipient) %50.050.050.0 Total organic solids (TOS) b %40.039.739.9 Activity/TOS ratio U/mg TOS1.001.021.01 a UNIT: U/g (see Section 3.3.1). b TOS calculated as 100% – % water – % ash – % excipient. Composition of the food enzyme preparation. UNIT: U/g (see Section 3.3.1). TOS calculated as 100% – % water – % ash – % excipient. Purity The lead content in all batches was below 0.18 mg/kg, 21 which complies with the specification for lead as laid down in the general specifications for enzymes used in food processing (FAO/WHO, 2006). For arsenic, the average concentration determined in all batches was 0.38 mg/kg. 22 , 23 The Panel considered this concentration as not of concern. The food enzyme preparation complies with the microbiological criteria for total coliforms, Escherichia coli and Salmonella, as laid down in the general specifications for enzymes used in food processing (FAO/WHO, 2006). 24 No antimicrobial activity was detected in any of the tested batches. 25 The Panel considered that the information provided on the purity of the food enzyme was sufficient. Viable cells and DNA of the production strain The absence of viable cells of the production strain in the food enzyme was demonstrated ■■■■■. No colonies were detected. A positive control was included. 26 The absence of recombinant DNA in the food enzyme was analysed ■■■■■ ■■■■■ ■■■■■, the Panel could not conclude on the absence of recombinant DNA in the food enzyme. 28 Toxicological data No toxicological tests were provided by the applicant. Although all other requirements for the QPS have been met, the production strain carries multiple copies of acquired AMR gene and therefore cannot be considered suitable for the QPS approach. In addition, the absence of recombinant DNA of the production organism could not be demonstrated. However, no toxicological risk is expected from the possible presence of this AMR genes in the food enzyme (Section 3.3.4.). As no other concerns arising from the microbial source or from the manufacturing process have been identified, the Panel considered that no toxicological studies other than assessment of allergenicity are needed for the assessment of this food enzyme. Allergenicity The allergenicity assessment considered only the food enzyme and not additives, carriers or other excipients that may be used in the final formulation. The potential allergenicity of the glutaminase produced with the Bacillus subtilis strain Glu3‐3 was assessed by comparing its amino acid sequence with those of known allergens as described in the EFSA GMO Scientific Opinion (EFSA GMO Panel, 2010). Using higher than 35% identity in a sliding window of 80 amino acids as the criterion, no match was found in the AllergenOnline database. 29 No reports on oral or respiratory sensitisation or elicitation reactions of the food enzyme under assessment have been published. 30 No allergic reactions upon dietary exposure to any glutaminase have been reported in the literature. 31 The Panel considered that the results of the sequence homology search and the available literature do not indicate a risk of allergic reactions upon dietary exposure to the glutaminase under assessment. The production strain belongs to the B. subtilis species; some strains from this species are known to produce the food allergens poly‐γ‐glutamic acid and the subtilisin‐like serine protease Bac s 1 (nattokinase). Few case reports of allergic reactions after consumption of natto produced by B. subtilis have been reported (Inomata et al., 2012; Suzuki et al., 2023). The biomass is removed during the production process; however, allergenic proteins of the production strain can be released into the culture medium from which the food enzyme is obtained. ■■■■■, known sources of allergens, are present in the culture medium. During the fermentation process, these products will mostly be degraded and utilised by the production strain. Taken together, concerning the potential allergic reactions due to the production strain and the raw material in the culture medium, the Panel considered that residual amounts of allergenic proteins could be present in the food enzyme. Taking into account the level of dietary exposure (see Section 3.5), this would result in minute amounts in the final foods, from which allergic reactions are usually not expected. In conclusion, the Panel considered that under the intended conditions of use, a risk of allergic reactions upon dietary exposure to this food enzyme cannot be excluded, but that the likelihood is low. Dietary exposure Intended use of the food enzyme The food enzyme is intended to be used in seven food manufacturing processes at the recommended use levels summarised in Table 2. TABLE 2Intended uses and recommended use levels of the food enzyme as provided by the applicant. 32 Food manufacturing process a Raw material (RM)Recommended use level (mg TOS/kg RM) b , c Processing of dairy products Production of flavouring preparations from dairy products Cheese, cream, butter, etc.19.5–3900 Processing of egg and egg productsEggs39–1950 Processing of meat and fish products Production of protein hydrolysates from meat and fish proteins Meat and fish protein390–3900 Processing of cereals and other grains Production of baked products Flour39–1950 Production of cereal‐based products other than baked Flour39–1950 Processing of plant‐ and fungal‐derived products Production of protein hydrolysates from plants and fungi Plant and fungal proteins390–3900 Processing of yeast and yeast productsYeast390–19,500 Abbreviation: TOS, total organic solids. a The name has been harmonised by EFSA in accordance with the ‘Food manufacturing processes and technical data used in the exposure assessment of food enzymes’ (EFSA CEP Panel, 2023). b Based on 1.008 U/mg TOS. c The numbers in bold were used for calculation. Intended uses and recommended use levels of the food enzyme as provided by the applicant. 32 Production of flavouring preparations from dairy products Production of flavouring preparations from dairy products Production of protein hydrolysates from meat and fish proteins Production of protein hydrolysates from meat and fish proteins Production of baked products Production of baked products Production of cereal‐based products other than baked Production of cereal‐based products other than baked Production of protein hydrolysates from plants and fungi Production of protein hydrolysates from plants and fungi Abbreviation: TOS, total organic solids. The name has been harmonised by EFSA in accordance with the ‘Food manufacturing processes and technical data used in the exposure assessment of food enzymes’ (EFSA CEP Panel, 2023). Based on 1.008 U/mg TOS. The numbers in bold were used for calculation. In all food manufacturing processes, the release of l‐glutamic acid catalysed by the food enzyme contributes to the improvement of the sensory properties of the final foods and food ingredients. In the production of flavouring preparations from dairy products, the food enzyme is added to dairy products (e.g. cream, cheese, butter) before pasteurisation. 33 The food enzyme–TOS remain in the final foods. In the processing of egg and egg products, the food enzyme is added to the purified egg protein. 34 The food enzyme–TOS remain in the final foods. In the production of protein hydrolysates, the food enzyme is added to a variety of protein‐rich materials from animal (e.g. meat, fish, gelatine, collagen) or plant (e.g. soy, wheat, maize) 35 sources. The food enzyme–TOS remain in the final protein hydrolysates. In the production of baked products and cereal‐based products other than baked, the food enzyme is added to flour during dough making. 36 The food enzyme–TOS remain in the final baked products. In the processing of yeast and yeast products, the glutaminase is added to the yeast cream. 37 , 38 The food enzyme–TOS remain in the final yeast products. Based on data provided on thermostability (see Section 3.3.1) and the downstream processing within the respective food manufacturing processes, the Panel considered that the food enzyme is inactivated during the production of cereal‐based products other than baked and in the processing of yeast and yeast products. However, it may remain in its active form in the other food manufacturing processes listed in Table 2, depending on the heat treatment conditions. Dietary exposure estimation Chronic exposure to the food enzyme–TOS was calculated using the FEIM webtool 39 by combining the maximum recommended use level with individual consumption data (EFSA CEP Panel, 2021). The estimation involved selection of relevant food categories and application of technical conversion factors (EFSA CEP Panel, 2023). Table 3 provides an overview of the derived exposure estimates across all surveys. Detailed mean and 95th percentile exposure to the food enzyme–TOS per age class, country and survey, as well as contribution from each FoodEx category to the total dietary exposure are reported in Appendix A – Tables 1 and 2. For the present assessment, food consumption data were available from 51 dietary surveys (covering infants, toddlers, children, adolescents, adults and the elderly), carried out in 27 European countries (Appendix B). The highest dietary exposure was estimated to be 29.311 mg TOS/kg bw per day in toddlers at the 95th percentile. TABLE 3Summary of the estimated dietary exposure to the food enzyme–TOS in six population groups.Population groupEstimated exposure (mg TOS/kg body weight per day)InfantsToddlersChildrenAdolescentsAdultsThe elderly Age range 4–11 months12–35 months3–9 years10–17 years18–64 years≥ 65 years Min–max mean (number of surveys)1.908–10.703 (14)5.442–16.106 (17)3.444–13.579 (21)1.043–8.613 (23)2.611–5.003 (23)2.275–4.880 (25) Min–max 95th percentile (number of surveys)5.592–26.873 (13)12.518–29.311 (16)7.239–25.355 (21)2.436–15.079 (22)5.035–10.906 (23)4.564–8.980 (24)Abbreviation: TOS: total organic solids. Summary of the estimated dietary exposure to the food enzyme–TOS in six population groups. Abbreviation: TOS: total organic solids. Uncertainty analysis In accordance with the guidance provided in the EFSA opinion related to uncertainties in dietary exposure assessment (EFSA, 2006), the following sources of uncertainties have been considered and are summarised in Table 4. TABLE 4Qualitative evaluation of the influence of uncertainties on the dietary exposure estimate.Sources of uncertaintiesDirection of impact Model input data Consumption data: different methodologies/representativeness/underreporting/misreporting/no portion size standard+/−Use of data from food consumption surveys of a few days to estimate long‐term (chronic) exposure for high percentiles (95th percentile)+Possible national differences in categorisation and classification of food+/− Model assumptions and factors Selection of broad FoodEx categories for the exposure assessment+Exposure to food enzyme–TOS always calculated based on the recommended maximum use level+Use of recipe fractions to disaggregate FoodEx categories+/−Use of technical factors in the exposure model+/− Note: +, uncertainty with potential to cause overestimation of exposure; –, uncertainty with potential to cause underestimation of exposure. Qualitative evaluation of the influence of uncertainties on the dietary exposure estimate. Note: +, uncertainty with potential to cause overestimation of exposure; –, uncertainty with potential to cause underestimation of exposure. The conservative approach applied to estimate the dietary exposure to the food enzyme–TOS, in particular assumptions made on the occurrence and use levels of this specific food enzyme, is likely to have led to an overestimation of the exposure. Margin of exposure Since no toxicological assessment was considered necessary by the Panel, a margin of exposure was not calculated. CONCLUSIONS The production strain of the food enzyme contains multiple copies of acquired AMR genes. As the absence of DNA from the production organism in the food enzyme could not be demonstrated, the Panel could not conclude on the safety of the food enzyme glutaminase produced with the genetically modified B. subtilis strain Glu3‐3. DOCUMENTATION AS PROVIDED TO EFSA Dossier and additional information can be accessed at https://open.efsa.europa.eu/dossier/FEN‐2024‐33010. ABBREVIATIONS antimicrobial resistance body weight EFSA Panel on Food Contact Materials, Enzymes and Processing Aids European Inventory of Existing Commercial Chemical Substances Food and Agricultural Organization of the United Nations EFSA Panel on Food Enzymes genetically modified organism International Union of Biochemistry and Molecular Biology Joint FAO/WHO Expert Committee on Food Additives kiloDalton limit of quantification polymerase chain reaction qualified presumption of safety total organic solids whole genome sequencing World Health Organization REQUESTOR European Commission QUESTION NUMBER EFSA‐Q‐2025‐00232 COPYRIGHT FOR NON‐EFSA CONTENT EFSA may include images or other content for which it does not hold copyright. In such cases, EFSA indicates the copyright holder and users should seek permission to reproduce the content from the original source. PANEL MEMBERS José Manuel Barat Baviera, Claudia Bolognesi, Francesco Catania, Gabriele Gadermaier, Ralf Greiner, Baltasar Mayo, Alicja Mortensen, Yrjö Henrik Roos, Marize de Lourdes Marzo Solano, Henk Van Loveren, Laurence Vernis, Holger Zorn. LEGAL NOTICE The published scientific output includes information items that have been redacted, in accordance with the confidentiality requests submitted by the applicant, pending a decision thereon by EFSA. Redactions may be subject to review once a decision on such confidentiality requests is taken by EFSA. Supporting information APPENDIX A Dietary exposure estimates to the food enzyme–TOS in details Dietary exposure estimates to the food enzyme–TOS in details Appendix A can be found in the online version of this output (in the ‘Supporting information’ section). The file contains two sheets, corresponding to two tables. Table 1: Average and 95th percentile exposure to the food enzyme–TOS per age class, country and survey. Table 2: Contribution of food categories to the dietary exposure to the food enzyme–TOS per age class, country and survey. Population groups considered for the exposure assessment PopulationAge rangeCountries with food consumption surveys covering more than 1 day Infants From 16 weeks on up to and including 11 months of ageBulgaria, Croatia, Cyprus, Denmark, Estonia, Finland, France, Germany, Italy, Latvia, Poland, Portugal, Slovenia, Spain Toddlers From 12 months up to and including 35 months of ageBelgium, Bulgaria, Croatia, Cyprus, Denmark, Estonia, Finland, France, Germany, Hungary, Italy, Latvia, Montenegro*, Netherlands, Poland, Portugal, Republic of North Macedonia*, Serbia*, Slovenia, Spain Children From 36 months up to and including 9 years of ageAustria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Italy, Latvia, Montenegro*, Netherlands, Poland, Portugal, Republic of North Macedonia*, Serbia*, Spain, Sweden Adolescents From 10 years up to and including 17 years of ageAustria, Belgium, Bosnia and Herzegovina*, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Italy, Latvia, Montenegro*, Netherlands, Poland, Portugal, Romania, Serbia*, Slovenia, Spain, Sweden Adults From 18 years up to and including 64 years of ageAustria, Belgium, Bosnia and Herzegovina*, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Montenegro*, Netherlands, Poland, Portugal, Romania, Serbia*, Slovenia, Spain, Sweden The elderly a From 65 years of age and olderAustria, Belgium, Croatia, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Montenegro*, Netherlands, Poland, Portugal, Romania, Serbia*, Slovenia, Spain, Sweden*Consumption data from these pre‐accession countries are not reported in Table 3 of this opinion, however, they are included in Appendix B for testing purpose. a The terms ‘children’ and ‘the elderly’ correspond, respectively, to ‘other children’ and the merge of ‘elderly’ and ‘very elderly’ in the Guidance of EFSA on the ‘Use of the EFSA Comprehensive European Food Consumption Database in Exposure Assessment’ (EFSA, 2011). Consumption data from these pre‐accession countries are not reported in Table 3 of this opinion, however, they are included in Appendix B for testing purpose. The terms ‘children’ and ‘the elderly’ correspond, respectively, to ‘other children’ and the merge of ‘elderly’ and ‘very elderly’ in the Guidance of EFSA on the ‘Use of the EFSA Comprehensive European Food Consumption Database in Exposure Assessment’ (EFSA, 2011). EFSA FEZ Panel (EFSA Panel on Food Enzymes) , Zorn, H. , Barat Baviera, J. M. , Bolognesi, C. , Catania, F. , Gadermaier, G. , Greiner, R. , Mayo, B. , Mortensen, A. , Roos, Y. H. , Solano, M. L. M. , Van Loveren, H. , Vernis, L. , Aguilera, J. , Andryszkiewicz, M. , Cavanna, D. , & Liu, Y. (2026). Safety evaluation of the food enzyme glutaminase from the genetically modified Bacillus subtilis strain Glu3‐3. EFSA Journal, 24(5), e10088. 10.2903/j.efsa.2026.10088 Adopted: 15 April 2026 Correspondence: Ask a Question The declarations of interest of all scientific experts active in EFSA's work are available at https://open.efsa.europa.eu/experts. Notes Regulation (EC) No 1332/2008 of the European Parliament and of the Council of 16 December 2008 on Food Enzymes and Amending Council Directive 83/417/EEC, Council Regulation (EC) No 1493/1999, Directive 2000/13/EC, Council Directive 2001/112/EC and Regulation (EC) No 258/97. OJ L 354, 31.12.2008, pp. 7–15. Regulation (EC) No 1331/2008 of the European Parliament and of the Council of 16 December 2008 establishing a common authorisation procedure for food additives, food enzymes and food flavourings. OJ L 354, 31.12.2008, pp. 1–6. Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety. OJ L 31, 1.2.2002, pp. 1–24. Accessible at https://open.efsa.europa.eu/consultations/a0cTk00000TCIh1IAH?search=2025‐00232. Technical Dossier/Risk Assessment/Source of the food enzyme/Annex 01. Technical Dossier/Risk Assessment/Source of the food enzyme/Annex 05. https://zenodo.org/records/7554079. Technical Dossier Additional data December 2025/Source of the food enzyme/Appendix 1. Technical dossier/Additional data December 20205/Source of the food enzyme/Responses to the RFI Dated 21 October 2025. Technical Dossier/Risk Assessment/Source of the food enzyme/Source of the food enzyme. Technical dossier/Additional data December 20205/Responses to the RFI Dated 21 October 2025. Regulation (EC) No 852/2004 of the European Parliament and of the Council of 29 April 2004 on the hygiene of foodstuffs. OJ L 226, 25.6.2004, pp. 3–21. Technical Dossier/Risk Assessment/Manufacturing process of the food enzyme/Annexes 13 to 16. Technical Dossier/Risk Assessment/Manufacturing process of the food enzyme. Technical Dossier/Risk Assessment/Manufacturing process of the food enzyme/Annex 17. Technical Dossier/Risk Assessment/Chemical composition, properties and purity of the food enzyme/Allergenicity/Annex 33. Technical Dossier/Risk Assessment/Chemical composition, properties and purity of the food enzyme. Technical Dossier/Risk Assessment/Chemical composition, properties and purity of the food enzyme/Annexes 21‐1 and 21‐2. Technical Dossier/Risk Assessment/Chemical composition, properties and purity of the food enzyme. Technical Dossier/Risk Assessment/Chemical composition, properties and purity of the food enzyme/Annex 18_1 and Methods of analysis/Annex 21_1, Annex 22, Annex 23, Annex 31_1, Annex 31_2 and Annex 32. Technical Dossier/Risk Assessment/Chemical composition, properties and purity of the food enzyme/Annex 18_1 and Methods of analysis/Annexes 25 and 32. LoQs: Pb = 0.04 mg/kg; As = 0.01 mg/kg. Technical Dossier/Risk Assessment/Chemical composition, properties and purity of the food enzyme/Annex 18_1 and Methods of analysis/Annexes 24 and 32. Technical Dossier/Risk Assessment/Chemical composition, properties and purity of the food enzyme/Annex 18_1 and Methods of analysis/Annex 26 to 29 and Annex 32. Technical Dossier/Risk Assessment/Chemical composition, properties and purity of the food enzyme/Annex 19_3 and Methods of analysis/Annexes 30 and 32. Technical Dossier/Risk Assessment/Source of the food enzyme/Annex 10. Technical dossier/Annex 11. Technical Dossier/Additional data December 2025/Source of the food enzyme/Appendix 2. Technical Dossier/Risk Assessment/Allergenicity/Annex 33. Technical Dossier/Additional data December 2025/Allergenicity. Technical Dossier/Additional data December 2025/Allergenicity. Technical dossier/Additional data December 2025/Intended use(s) in food and use level(s)/Appendix 3/Table 1. Technical dossier/Additional data December 2025/Annex 3/Figure 1. Technical dossier/Additional data December 2025/Annex 3/Figure 2. Technical dossier/Additional data December 2025/Annex 3/Figure 3. Technical dossier/Additional data December 2025/Annex 3/Figures 4 and 5. Additional data December 2025/Annex 3/p. 7. Additional data December 2025/Source of the food enzyme/Responses to the RFI Dated 21 October 2025/Answer 7. Version 1.1.1. REFERENCES Associated Data Supplementary Materials APPENDIX A Dietary exposure estimates to the food enzyme–TOS in details